FDA DEVICE FACTS
Beacon EUS Access System
Covidien, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Beacon EUS Access System is used to access the following areas of the gastrointestinal tract: the intra- or extra-hepatic bile ducts, pancreatic ducts, cystic duct, gallbladder or for delivery of injectable materials into tissues through the accessory channel of an ultrasound endoscope. CONFIDENTIAL Covidien llc Volume 1 of 2 Technological Characteristics of the Device Compared to Predicate Devices The subject device has many of the same technological characteristics as the predicate devices. All devices are sterile, single-use, manual devices used in the gastrointestinal tract. The devices are designed to be used through the accessory channel of an ultrasound endoscope and mount to the endoscope via a metal luer adapter located on the handle. All devices have delivery system handles with a series of slidable sub-sections and a catheter sheath. All device systems have metallic removable sharp needles or stylets that pierce tissue. The primary difference in technological characteristics of the subject device from the predicate devices is the pre-curved design of the removable Beacon EUS Access Needle. The Beacon EUS Access Needle consists of a pre-curved cannula and sharp stylet. Once the stylet is removed from the cannula it takes on a curved shape.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。